| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.003 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.29 | 3e-06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0006 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0006 |